The price of TSBX is predicted to go up -0.96%, based on the high correlation periods with BSRR. The similarity of these two price pattern on the periods is 93.33%.
TSBX
BSRR
Down: -0.96%Similarity: 93.33%
TSBX Revenue Forecast
TSBX EPS Forecast
TSBX FAQs
What is bull’s view on TSBX?
TSBX stock is currently trading at $0.4819, reflecting a significant decline from its recent high due to disappointing Q2 EPS results and a 60% workforce reduction. Bulls argue that the restructuring, focusing on TIDAL-01 and extending the cash runway to Q2 2026, positions the company for long-term growth in oncology. However, with RSI at 41.86 and MACD showing no clear momentum, the stock remains under pressure in the short term.
What is bear's view on TSBX?
TSBX stock is bearish, trading at $1.0598 after a 52% drop due to disappointing Q2 EPS results. The company's restructuring, including a 60% workforce reduction, aims to extend its cash runway but signals financial instability. Weak fundamentals and poor market sentiment suggest further downside risk.